Global Healthcare Analyst

Tina Banerjee

Equity Bottom-Up

Hapvida Participacoes e Invest / Equity Bottom-Up

<ul>
<li>The business combination of <a href="https://www.smartkarma.com/entities/hapvida-participacoes-e-inve" target="_blank" data-smartkarma-citation="entities:27870:1" rel="noopener">Hapvida Participacoes E Inve (HAPV3 BZ)</a> and <a href="https://www.smartkarma.com/entities/notre-dame-intermed-par-sa" target="_blank" data-smartkarma-citation="entities:27865:1" rel="noopener">Notre Dame Intermed Par SA (GNDI3 BZ)</a> concluded on Feb 11. GNDI3 shares are no longer trading.</li>
<li>Since Feb 14, 2022, GNDI has become a wholly-owned subsidiary of Hapvida. The combined business has become Brazil’s largest vertical healthcare operator, with a market share of approximately 18%.</li>
<li>The combined company estimates operational synergies of BRL1.38 billion during 2022–2024. With a share of 58%, revenue is expected to be the biggest contributor of the synergies.</li>
</ul>


The business combination of Hapvida Participacoes E Inve (HAPV3 BZ) and Notre Dame Intermed Par SA (GNDI3 BZ) concluded on Feb 11. GNDI3 shares are no longer trading.
Since Feb 14, 2022, GNDI has become a wholly-owned subsidiary of Hapvida. The combined business has become Brazil’s largest vertical healthcare operator, with a market share of approximately 18%.
The combined company estimates operational synergies of BRL1.38 billion during 2022–2024. With a share of 58%, revenue is expected to be the biggest contributor of the synergies.


Hapvida (HAPV3 BZ) And Grupo Notredame (GNDI3 BZ) Business Combination- Potential Value Generation

Brazil

Notre Dame Intermedica Participacoes S.A. provides managed health care services. The Company offers health, dental, and occupational health care plans. Notre Dame Intermedica Participacoes provides its services in the own and accredited networks of clinical centers, hospitals, emergency rooms, maternity, and dental clinics.

Notre Dame Intermedica Partici (GNDI3 BZ)

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Hapvida (HAPV3 BZ) And Grupo Notredame (GNDI3 BZ) Business Combination- Potential Value Generation

Hapvida is expecting incremental EBITDA of BRL1.38 billion during 2022–2024 from the acquisition of GNDI. Hapvida is expected to gain market share...

Tina Banerjee